Lisata Therapeutics (LSTA) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $4.6 million.
- Lisata Therapeutics' Total Current Liabilities fell 262.2% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 262.2%. This contributed to the annual value of $5.6 million for FY2024, which is 1482.55% down from last year.
- Per Lisata Therapeutics' latest filing, its Total Current Liabilities stood at $4.6 million for Q3 2025, which was down 262.2% from $4.3 million recorded in Q2 2025.
- Lisata Therapeutics' Total Current Liabilities' 5-year high stood at $6.6 million during Q4 2023, with a 5-year trough of $3.8 million in Q1 2025.
- In the last 3 years, Lisata Therapeutics' Total Current Liabilities had a median value of $4.7 million in 2024 and averaged $4.9 million.
- Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 231.86% in 2024, then plummeted by 2861.43% in 2025.
- Lisata Therapeutics' Total Current Liabilities (Quarter) stood at $6.6 million in 2023, then fell by 14.83% to $5.6 million in 2024, then dropped by 18.62% to $4.6 million in 2025.
- Its Total Current Liabilities stands at $4.6 million for Q3 2025, versus $4.3 million for Q2 2025 and $3.8 million for Q1 2025.